Tag
This article reviews evidence supporting OCT measurements of retinal layers as biomarkers for predicting multiple sclerosis progression and highlights the need for further research to enhance clinical application.
Recent guideline updates elevate intravascular ultrasound (IVUS) and optical coherence tomography (OCT) from optional tools to Class I, Level A strategies for many complex percutaneous coronary interventions, driven by randomized trials and
A clear, clinician-focused summary of the 2026 EAPCI/EBC consensus recommending routine intravascular imaging (IVUS/OCT) to plan, guide and optimize left main bifurcation PCI — with practical steps, controversies and implementation advice.
Early rapid optic nerve head swelling in NAION correlates with worse visual outcomes, with OCT measures of pONHV and mGCIPL thinning providing prognostic insights within days of symptom onset.
This review synthesizes longitudinal OCT findings and clinical outcomes in NAION, highlighting the prognostic value of early optic nerve head swelling rates for visual impairment progression, and discusses mechanistic and translational impl
Unsupervised clustering defines three structural phenotypes in chronic CSC, linking photoreceptor damage with choroidal changes and visual prognosis, refining disease stratification beyond photoreceptor staging alone.
A stress test measuring intraocular pressure identifies glaucoma patients at risk of rapid progression despite normal office pressure readings, offering complementary prognostic insights beyond routine checks.
A new prospective cohort study suggests that retinal nerve fiber layer thickness on neonatal OCT at 36 weeks’ PMA may help predict 2-year motor and cognitive outcomes in very preterm infants.
A 5-year follow-up of the RENOVATE-COMPLEX-PCI trial demonstrates that intravascular imaging-guided PCI significantly reduces major adverse cardiac events by 32% compared to angiography alone in complex lesions, highlighting the long-term c
This study examines the morphology of high-risk plaques in non-culprit coronary lesions among NSTEMI and STEMI patients and their impact on clinical outcomes, suggesting comparable prevalence of high-risk features but differing plaque chara
